The latest price target for Sotera Health (NASDAQ:SHC) was reported by BMO Capital on November 13, 2025. The analyst firm set a price target for $19.00 expecting SHC to rise to within 12 months (a possible 13.81% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Sotera Health (NASDAQ:SHC) was provided by BMO Capital, and Sotera Health initiated their outperform rating.

The last upgrade for Sotera Health Co happened on May 5, 2025 when Goldman Sachs raised their price target to $17. Goldman Sachs previously had a neutral for Sotera Health Co.

There is no last downgrade for Sotera Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sotera Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sotera Health was filed on November 13, 2025 so you should expect the next rating to be made available sometime around November 13, 2026.

While ratings are subjective and will change, the latest Sotera Health (SHC) rating was a initiated with a price target of $0.00 to $19.00. The current price Sotera Health (SHC) is trading at is $16.70, which is within the analyst’s predicted range.